Management of Relapsed/Refractory Primary Membranous Nephropathy

Created using ChatSlide

This training focuses on understanding the recurrence of primary membranous nephropathy (pMN), the challenges in its management, and recent epidemiological trends. It explores the KDIGO 2021 guidelines, prognostic markers, and the role of proteinuria and GFR in patient outcomes. Therapeutic strategies, including Rituximab and approaches for treatment resistance, are discussed alongside personalized medicine applications like immunomonitoring and individualized regimens. The session concludes...